This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’
Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics…
Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnology with electronics comes with on-board sensors that enable clinicians to monitor and control an implant’s drug production process. The post This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’ appeared first…
Cigna’s exit from the ACA individual market is causing one healthcare expert to question the long-term potential of ICHRA. The post Could Cigna Exiting the Individual Market be an Indictment of ICHRA? appeared first on MedCity News.
A new report from PayZen found that providers collect just 31% of patient bills on average, even as patient payments account for a growing share of health system revenue. PayZen executive Tobias Mezger outlined how providers can improve the patient financial experience through clearer pre-care payment conversations and more flexible financing options. The post What…
When demand fluctuates, even slightly, the margin for error becomes clear – highlighting the urgent need for greater efficiency to meet rising procedural demand. The post What Seasonal Pressures Continue to Teach Us About the Fragility of the US Surgical System appeared first on MedCity News.
Hospitals who prioritize patient understanding achieve better operational outcomes. Higher surgical conversion rates, increased patient retention, and repeat engagement produce measurable performance gains. The post When Patients Understand, Hospitals Grow appeared first on MedCity News.
Delayed remediation and patch latency are no longer just IT and security metrics; they serve as direct reflections of leadership priorities. The post The Hidden Cost of Slow Cyber Remediation in Healthcare appeared first on MedCity News.
KFF Health News chief Washington correspondent Julie Rovner discussed federal policy on vaccine research, vaping, and drug access on Science Friday on May 8. Rovner also discussed the Supreme Court decision on the abortion pill mifepristone on NPR’s Morning Edition on May 5. Click here to hear Rovner on Science Friday. Click here to hear…
IKS Health acquired healthcare AI startup ARAI to strengthen the technology underpinning its automation tools, as well as reduce its dependence on third-party AI models. The post IKS Health Acquires ARAI to Build Out Specialized AI Stack appeared first on MedCity News.
Anomaly’s $17 million round was led by Sound Ventures and included participation from Alumni Ventures, Link Ventures, Redesign Health and RRE Ventures. The post Anomaly Raises $17M for AI-Powered Payer Intelligence Platform appeared first on MedCity News.
The full FDA clinical hold formally halts all tests of Aardvark Therapeutics’ drug for Prader-Willi syndrome, a rare inherited metabolic disorder that leads to excessive eating. Earlier this year, Aardvark voluntarily paused all tests of its small molecule after a cardiovascular problem emerged in a healthy volunteer. The post Under FDA Clinical Hold, Aardvark Therapeutics…